Indication
Pars Plana Vitrectomy
3 clinical trials
4 products
Clinical trial
Safety and Preliminary Efficacy of Two Dose Levels of HydroLenz as a Protectant for Vitrectomy-Induced Lens Opacities in Subjects Undergoing VitrectomyStatus: Not yet recruiting, Estimated PCD: 2025-01-01
Product
HydroLenzClinical trial
Microinvasive Pars Plana Vitrectomy Combined ILM Peeling Versus Anti-VEGF Intravitreal Injection for Treatment-naïve Diabetic Macular EdemaStatus: Recruiting, Estimated PCD: 2025-09-05
Product
ConberceptClinical trial
Compare the Efficacy of VItrectomy Combined With DExamethasone Implant Versus With Aflibercept in DME Patients Diagnosed by Intraoperative OCT (the VIDEO Study): Study Protocol for a Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-10-01
Product
OzurdexProduct
Aflibercept